Össur Acquires Naked Prosthetics

Össur has acquired Naked Prosthetics, a leading provider of durable, custom and functional finger prostheses for finger and partial hand amputees, with effect from 26 August 2022. The mechanical devices are individually designed to mimic the natural motion of the finger.

The acquisition addresses a critical need for patients with finger and partial hand loss, traditionally an underserved yet growing population. It is a welcome addition to the Össur product portfolio as it strengthens Össur’s upper limb product offering globally and allows Össur to address a broader group of amputees seeking to live a Life Without Limitations.

The Company has around 70 employees and is located in the US, in Olympia, Washington. In 2021, Naked Prosthetics’ sales amounted to USD 9 million.

The acquisition will not have an impact on the financial guidance provided for the full year.

Sveinn Sölvason, President and CEO of Össur:

“Naked Prosthetics has developed functional and high-quality finger prostheses that complement our product portfolio and add an important range to our upper limb product offering. The acquisition strengthens our global market position, and we are pleased to welcome the employees of Naked Prosthetics to the Össur team.”

Bob Thompson, CEO of Naked Prosthetics:

“Össur’s global reach and expertise make them an obvious and welcome next step for Naked Prosthetics’ goal of getting more finger amputees back to work and doing what they love. We are excited to join forces with the Össur team and continue to grow the partial-hand prosthetic market.”

SourceÖssur

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.